Related references
Note: Only part of the references are listed.Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4]thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase
Mark J. Karbarz et al.
ANESTHESIA AND ANALGESIA (2009)
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo
Tiziana Bisogno et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Excitation of cutaneous C nociceptors by intraplantar administration of anandamide
Carl Potenzieri et al.
BRAIN RESEARCH (2009)
Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects
Natalia Lozovaya et al.
CELL CALCIUM (2009)
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Kay Ahn et al.
CHEMISTRY & BIOLOGY (2009)
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
Rita Nyilas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia
Giuseppe D'Agostino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Substance P Drives Endocannabinoid-Mediated Disinhibition in a Midbrain Descending Analgesic Pathway
Geoffrey M. Drew et al.
JOURNAL OF NEUROSCIENCE (2009)
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
S. G. Kinsey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain
Leonardo Guasti et al.
MOLECULAR PAIN (2009)
A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist
Natasha T. Snider et al.
MOLECULAR PHARMACOLOGY (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain
Anna Leichsenring et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury
Alfonso Romero-Sandoval et al.
ANESTHESIOLOGY (2008)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Inhibition of fatty acid amide hydrolase produces PPAR-α-mediated analgesia in a rat model of inflammatory pain
D. R. Sagar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Prostaglandin E-2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NF kappa B activity
S. Shu-Jung Hu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Kay Ahn et al.
CHEMICAL REVIEWS (2008)
Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats
M. D. Jhaveri et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Anandamide effects on 5-HT3 receptors in vivo
Ildiko Racz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
Wataru Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis
Delphine Staumont-Salle et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Identification of novel endogenous cytochrome P450 arachidonate metabolites with high affinity for cannabinoid receptors
Jian-Kang Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain
Gabriel M. Simon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation
Armen N. Akopian et al.
JOURNAL OF NEUROSCIENCE (2008)
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
Ildiko Racz et al.
JOURNAL OF NEUROSCIENCE (2008)
Interferon-γ Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain
Ildiko Racz et al.
JOURNAL OF NEUROSCIENCE (2008)
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release
Yuki Hashimotodani et al.
NEUROPHARMACOLOGY (2008)
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain
Maulik D. Jhaveri et al.
NEUROPHARMACOLOGY (2008)
Microglia produce and hydrolyze palmitoylethanolamide
Giulio G. Muccioli et al.
NEUROPHARMACOLOGY (2008)
Multiple pathways involved in the biosynthesis of anandamide
Jie Liu et al.
NEUROPHARMACOLOGY (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain:: A new perspective on N-acylethanolamines as Neural Signaling Molecules
Michaela Egertova et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation
F. Comelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Novel cannabinoid receptors
A. J. Brown
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action
C. J. Fowler
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The complications of promiscuity: endocannabinoid action and metabolism
S. P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid activation of PPARα;: a novel neuroprotective mechanism
Y. Sun et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The endocannabinoid anandamide inhibits the function of α4β2 nicotinic acetylcholine receptors
Charles E. Spivak et al.
MOLECULAR PHARMACOLOGY (2007)
Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain
Maulik D. Jhaveri et al.
MOLECULAR NEUROBIOLOGY (2007)
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-α receptor agonist GW7647
Roberto Russo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
Roberto Russo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells
Giulio G. Muccioli et al.
JOURNAL OF NEUROSCIENCE (2007)
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors
S. Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets
Di Zhang et al.
NEUROPHARMACOLOGY (2007)
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats
Stefania Petrosino et al.
NEUROPHARMACOLOGY (2007)
Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro
S. Vandevoorde et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity
Nan Sang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The N-acylethanolamine-hydrolyzing acid amidase (NAAA)
Kazuhito Tsuboi et al.
CHEMISTRY & BIODIVERSITY (2007)
The multiple pathways of endocannabinoid metabolism: A zoom out
Severine Vandevoorde et al.
CHEMISTRY & BIODIVERSITY (2007)
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Leon Chang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain
Somsak Mitrirattanakul et al.
PAIN (2006)
A second fatty acid amide hydrolase with variable distribution among placental mammals
Binqing Q. Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α
Jesse LoVerme et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Localization of diacylglycerol lipase-α around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor
T Yoshida et al.
JOURNAL OF NEUROSCIENCE (2006)
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachiclonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons
Nan Sang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
CB2 cannabinoid receptor mediation of antinociception
Mohab M. Ibrahim et al.
PAIN (2006)
The role of the peroxisome proliferator-activated receptor-α (PPAR-α) in the regulation of acute inflammation
Salvatore Cuzzocrea et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids
D Leung et al.
BIOCHEMISTRY (2006)
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms
M Beltramo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha
X Fang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The function of microglia through purinergic receptors: Neuropathic pain and cytokine release
K Inoue
PHARMACOLOGY & THERAPEUTICS (2006)
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat
SJR Elmes et al.
PAIN (2005)
Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons
HI Kim et al.
BRAIN RESEARCH (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats
DR Sagar et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma
T Genovese et al.
EXPERIMENTAL NEUROLOGY (2005)
The endocannabinoid signalling system: Biochemical aspects
T Bisogno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597):: Effects on anandamide and oleoylethanolamide deactivation
D Fegley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons
AS Tahim et al.
NEUROSCIENCE (2005)
Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry
A Weber et al.
JOURNAL OF LIPID RESEARCH (2004)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
EJ Carrier et al.
MOLECULAR PHARMACOLOGY (2004)
Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR-α)
M Guzmán et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity
AH Lichtman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
AH Lichtman et al.
PAIN (2004)
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain
SJR Elmes et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat
DA Scott et al.
PAIN (2004)
Prostaglandin ethanolamides (prostamides): In vitro pharmacology and metabolism
I Matias et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation
S Kelly et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats
DP Finn et al.
NEUROPHARMACOLOGY (2003)
Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation
S Kelly et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
CB2 cannabinoid receptor agonists:: pain relief without psychoactive effects?
TP Malan et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
The CYP4A Isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands
LA Cowart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cannabinoid analgesia
JM Walker et al.
PHARMACOLOGY & THERAPEUTICS (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
AC Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Spinal administration of capsazepine inhibits noxious evoked responses of dorsal horn neurons in non-inflamed and carrageenan inflamed rats
S Kelly et al.
BRAIN RESEARCH (2002)
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
N Clayton et al.
PAIN (2002)
Oxidative metabolism of endocannabinoids
KR Kozak et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Cannabinoids: a real prospect for pain relief?
L Iversen et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo
S Kelly et al.
JOURNAL OF NEUROPHYSIOLOGY (2001)
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
CB2 cannabinoid receptor-mediated peripheral antinociception
TP Malan et al.
PAIN (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice
H Nakano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity
TA Samad et al.
NATURE (2001)
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
F Maingret et al.
EMBO JOURNAL (2001)
The vanilloid receptor: A molecular gateway to the pain pathway
MJ Caterina et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Pathways and mechanisms of N-acylethanolamine biosynthesis:: can anandamide be generated selectively?
HHO Schmid
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
P Beaulieu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Oxidative metabolism of anandamide
SH Burstein et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Share Paper
